In contrast, noticeably higher My1/De tumour weights were observed in group 6 (i.e., the pretreated BCR group) than in the CRLT/N group (p < 0.05 and p < 0.01; demonstrated in Table 2). This evidence concerns the gene BCR and neoplasm.